Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients.
Cheng G, Wang S, Li X, Li S, Zheng Y, Zhang L, Bao M, Liang C, Huang Z, Liu Y, Qin C, Shao P, Li J, Hua L, Yin C, Wang Z.
Cheng G, et al. Among authors: huang z.
Oncotarget. 2016 Aug 31;8(38):64427-64439. doi: 10.18632/oncotarget.11749. eCollection 2017 Sep 8.
Oncotarget. 2016.
PMID: 28969082
Free PMC article.